Better Buy: Valeant Pharmaceuticals International, Inc. vs. Rite Aid Corporation

If there was a "Bad News Bears" team for the healthcare sector, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Rite Aid (NYSE: RAD) would be starters on the team for sure. Valeant has lost over half of its market cap in the last 12 months, while Rite Aid's market cap has plunged nearly 70% in the same period.

Both companies are hoping to turn things around. But which beaten-down stock is the better buy? Here's how Valeant and Rite Aid compare.

Image source: Getty Images.

Continue reading


Source: Fool.com